{"id":2373,"date":"2021-06-21T18:00:00","date_gmt":"2021-06-21T18:00:00","guid":{"rendered":"https:\/\/www.govisachina.com\/?p=2373"},"modified":"2021-06-21T09:42:10","modified_gmt":"2021-06-21T09:42:10","slug":"chinas-sinopharm-covid-19-vaccines-arrive-in-thailand","status":"publish","type":"post","link":"https:\/\/www.govisachina.com\/zh\/2021\/06\/21\/chinas-sinopharm-covid-19-vaccines-arrive-in-thailand\/","title":{"rendered":"China&#8217;s Sinopharm COVID-19 vaccines arrive in Thailand"},"content":{"rendered":"<p class=\"wp-block-paragraph\">BANGKOK, June 20 (Xinhua) &#8212; A batch of China&#8217;s Sinopharm COVID-19 vaccines landed in the Thai capital of Bangkok Sunday, increasing support to the Southeast Asian country&#8217;s battle against its worst wave of outbreak so far.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The shipment, imported by the Chulabhorn Royal Academy (CRA), was transported to the Department of Medical Science for quality check after the arrival, the academy said in a post on its official Facebook account.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The CRA announced on Saturday that 17,070 organizations and companies nationwide had registered to obtain the Sinopharm vaccine to inoculate their employees.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The vaccines were considered as an alternative to the mass inoculation program launched by the government on June 7, which has been proceeded so far mainly with China&#8217;s Sinovac vaccines and locally-manufactured AstraZeneca vaccines.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The country approved the Sinopharm vaccine for emergency use in May, making it the fifth following the approvals of AstraZeneca, Sinovac, Johnson &amp; Johnson and Moderna vaccines.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Thailand aims to vaccinate about 70 percent of its nearly 70 million population by the end of the year. As of Saturday, it has administered more than 7.5 million doses of vaccines.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">On Sunday, the country reported 3,682 new cases, taking the total case tally to 218,131, with more than 85 percent of the infections confirmed since the third wave of outbreak began in early April.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Death toll from the viral disease increased by 20 to reach 1,629, according to the Center for the COVID-19 Situation Administration. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Source: http:\/\/www.xinhuanet.com\/english\/2021-06\/20\/c_1310018405.htm <\/p>","protected":false},"excerpt":{"rendered":"<p>BANGKOK, June 20 (Xinhua) &#8212; A batch of China&#8217;s Sinopharm COVID-19 vaccines landed in the Thai capital of Bangkok Sunday, increasing support to the Southeast Asian country&#8217;s battle against its worst wave of outbreak so far. The shipment, imported by the Chulabhorn Royal Academy (CRA), was transported to the Department [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[28,5],"tags":[],"class_list":["post-2373","post","type-post","status-publish","format-standard","hentry","category-covid-19","category-news"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":2421,"url":"https:\/\/www.govisachina.com\/zh\/2021\/07\/30\/roundup-chinese-covid-19-vaccines-effective-against-infection-mortality\/","url_meta":{"origin":2373,"position":0},"title":"Roundup: Chinese COVID-19 vaccines effective against infection, mortality","author":"Visa China","date":"30 7 \u6708, 2021","format":false,"excerpt":"BUENOS AIRES, July 30 (Xinhua) -- Experts in viral diseases and infectology have highlighted the efficacy of Chinese vaccines against COVID-19 and its new variants. \"According to the evidence available so far, vaccines that have been licensed by the World Health Organization (WHO) are effective against all variants in circulation\u2026","rel":"","context":"\u7c7b\u4f3c\u6587\u7ae0","block_context":{"text":"\u7c7b\u4f3c\u6587\u7ae0","link":""},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2202,"url":"https:\/\/www.govisachina.com\/zh\/2021\/05\/17\/chinas-sinopharm-covid-19-vaccine-likely-conducive-to-global-vaccine-accessibility-indian-newspaper\/","url_meta":{"origin":2373,"position":1},"title":"China&#8217;s Sinopharm COVID-19 vaccine likely conducive to global vaccine accessibility: Indian newspaper","author":"Visa China","date":"17 5 \u6708, 2021","format":false,"excerpt":"Xinhua\u00a0 NEW DELHI - China's Sinopharm COVID-19 vaccine, the first non-Western vaccine supported by the World Health Organization (WHO), is likely to be used in the COVAX program, which provides vaccines to low- and middle-income countries, reported the Indian Express newspaper Thursday. The WHO last week validated the China-developed vaccine\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2190,"url":"https:\/\/www.govisachina.com\/zh\/2021\/05\/10\/who-approval-of-sinopharm-vaccine-set-to-benefit-world-coronavirus-fight\/","url_meta":{"origin":2373,"position":2},"title":"WHO approval of Sinopharm vaccine set to benefit world coronavirus fight","author":"Visa China","date":"10 5 \u6708, 2021","format":false,"excerpt":"By BO LEUNG in London The World Health Organization's approval to give emergency use to the COVID-19 vaccine manufactured by China's Sinopharm has been welcomed by experts and health regulators worldwide. On Friday, the WHO gave the vaccine the green light, paving the way for potentially millions of doses to\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2467,"url":"https:\/\/www.govisachina.com\/zh\/2021\/08\/20\/malaysia-takes-first-delivery-of-chinas-cansino-covid-19-vaccine\/","url_meta":{"origin":2373,"position":3},"title":"Malaysia takes first delivery of China&#8217;s CanSino COVID-19 vaccine","author":"Visa China","date":"20 8 \u6708, 2021","format":false,"excerpt":"KUALA LUMPUR, Aug. 20 (Xinhua) -- The first batch of the single-dose COVID-19 vaccine developed by Chinese company CanSino Biologics arrived in Malaysia on Friday, boosting the country's capability in the fight against the pandemic. The first batch, comprising some 200,000 finished products, is part of a total of 3.5\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2401,"url":"https:\/\/www.govisachina.com\/zh\/2021\/07\/13\/providing-500-mln-vaccine-doses-to-world-china-aims-to-enhance-intl-cooperation-against-covid-19\/","url_meta":{"origin":2373,"position":4},"title":"Providing 500 mln vaccine doses to world, China aims to enhance int&#8217;l cooperation against COVID-19","author":"Visa China","date":"13 7 \u6708, 2021","format":false,"excerpt":"BEIJING, July 13 (Xinhua) -- Chinese vaccines are gathering steam across the world, injecting strong impetus into the global fight against COVID-19 as deaths from the virus topped 4 million worldwide and variants spread to more than 100 countries. As a steadfast advocate for equitable vaccine distribution around the globe,\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2314,"url":"https:\/\/www.govisachina.com\/zh\/2021\/06\/02\/who-validates-chinas-sinovac-covid-19-vaccine-for-emergency-use\/","url_meta":{"origin":2373,"position":5},"title":"WHO validates China&#8217;s Sinovac COVID-19 vaccine for emergency use","author":"Visa China","date":"2 6 \u6708, 2021","format":false,"excerpt":"GENEVA, June 1 (Xinhua) The World Health Organization (WHO) validated on Tuesday the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac for emergency use. \"I am happy to announce that the Sinovac coronavirus vaccine has been given WHO Emergency Use Listing (EUL) after being found to be safe, effective,\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2373","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/comments?post=2373"}],"version-history":[{"count":1,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2373\/revisions"}],"predecessor-version":[{"id":2374,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2373\/revisions\/2374"}],"wp:attachment":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/media?parent=2373"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/categories?post=2373"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/tags?post=2373"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}